Creating synthetic positive controls involves several steps and technologies. The process often begins with the identification of key molecular markers or antigens that need to be replicated. These markers are then synthesized using methods like recombinant DNA technology or peptide synthesis. The synthetic markers are embedded into a matrix that mimics the structural properties of natural tissues. This matrix can be composed of various materials, including hydrogels, polymers, or even engineered tissue scaffolds.
